BioCentury
ARTICLE | Company News

Antisoma acquires full rights to BC1-IL12

July 26, 2004 7:00 AM UTC

Antisoma (LSE:ASM; ASOM) acquired from partner EMD Lexigen Research Center (Billerica, Mass.) exclusive rights to BC1-IL12. Previously the partners shared co-development rights. The collaboration, which began in 2000, is no longer active. ...